Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000812295-17-000137
Filing Date
2017-06-12
Accepted
2017-06-12 14:46:11
Documents
1

Document Format Files

Seq Description Document Type Size
1 HERON HRTX 053117 hrtx5102017.txt SC 13G/A 5596
  Complete submission text file 0000812295-17-000137.txt   7628
Mailing Address 151 DETROIT ST. DENVER CO 80206-4805
Business Address 151 DETROIT ST. DENVER CO 80206-4805 3033333863
JANUS CAPITAL MANAGEMENT LLC (Filed by) CIK: 0000812295 (see all company filings)

EIN.: 753019302 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 0000

Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 6503662626
HERON THERAPEUTICS, INC. /DE/ (Subject) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-39444 | Film No.: 17906011
SIC: 2834 Pharmaceutical Preparations